Mackie Research Initiates Coverage on Mettrum Health Corp

- April 14th, 2016

Mackie Research Analyst Neal Gilmer has givenMettrum Health Corp. (TSXV:MT) a 12 month target price of $3.00, a premium of 105% to the $1.46 price.

Mackie Research Analyst Neal Gilmer has given Mettrum Health Corp. (TSXV:MT.V) a 12 month target price of $3.00, a premium of 105% to the $1.46 price.
Watch the full report:

Get the latest Agriculture Investing stock information

Get the latest information about companies associated with Agriculture Investing Delivered directly to your inbox.

Agriculture Investing

Select None
Select All

Leave a Reply